Search In this Thesis
   Search In this Thesis  
العنوان
Investigate the effect of Ezetimibe, Simvastatin, and Omega-3 fatty acids on Dyslipidemia patients :
المؤلف
Shamseldin, Yasmine Farouk.
هيئة الاعداد
باحث / ياسمين فاروق شمس الدين
مشرف / محمد منتصر خليفة
مشرف / أمل كمال حسين
مشرف / حسام الدين أحمد موافى
مشرف / حسن سلامة شلبي
الموضوع
Pharmacology. Therapeutics. Chemotherapy.
تاريخ النشر
2022.
عدد الصفحات
122 p. :
اللغة
الإنجليزية
الدرجة
الدكتوراه
التخصص
الصيدلة ، علم السموم والصيدلانيات
تاريخ الإجازة
1/1/2022
مكان الإجازة
جامعة المنيا - كلية الصيدلة - الصيدلة الإكلينيكية
الفهرس
Only 14 pages are availabe for public view

from 132

from 132

Abstract

As examined, dyslipidemia is one of the significant gamble
factors for cardiovascular sickness in DM. The accessibility of
different lipid-bringing down medications and enhancements
gives new open doors to patients to accomplish target lipid levels.
In any case, the greater part of these medications have serious
aftereffects that patients may not endure. It was important to
think twice about target levels of LDL, TG and TC also with the
most un-incidental effects. Consequently organization of the
tedious dosages of Omega 3 unsaturated fat ought to be thought
of, as it diminishes the gamble factors cardiovascular illness of
patients.
• Omega-3 fatty acid can be considered as an effective therapy
and treatment of choice for Dyslipidemia.
• Omega 3 Fatty acid have a significant effect on Triglycerides
and LDL, especially when added to ezetimibe.
• Ezetimibe enhance significantly decrease LDL and TG
especially in diabetic patients,